Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Other financing activities: 2018-2022

Historic Other financing activities for Avadel Pharmaceuticals (AVDL) over the last 2 years, with Dec 2022 value amounting to $1,000.

  • Avadel Pharmaceuticals' Other financing activities was N/A to $1,000 in Q4 2022 from the same period last year, while for Dec 2022 it was -$236,000, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2023, which is 9.30% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Other financing activities of $1,000 as of Q4 2022, which was up 102.78% from -$36,000 recorded in Q4 2019.
  • In the past 5 years, Avadel Pharmaceuticals' Other financing activities ranged from a high of $2.9 million in Q4 2018 and a low of -$129,000 during Q2 2019.
  • For the 1-year period, Avadel Pharmaceuticals' Other financing activities averaged around $1,000, with its median value being $1,000 (2022).
  • Data for Avadel Pharmaceuticals' Other financing activities shows a peak YoY increase of 95.74% (in 2019) and a maximum YoY decrease of 214.63% (in 2019) over the last 5 years.
  • Over the past 3 years, Avadel Pharmaceuticals' Other financing activities (Quarterly) stood at $2.9 million in 2018, then plummeted by 101.22% to -$36,000 in 2019, then reached $1,000 in 2022.
  • Its Other financing activities was $1,000 in Q4 2022, compared to -$36,000 in Q4 2019 and -$72,000 in Q3 2019.